Palexia Range 50 mg. 75 mg. 100 mg Tablet.
PDF Leaflet Revision Date: 25 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term relief of acute moderately severe post-operative pain in adults.
Dosage (summary)
50 to 100 mg every 4 to 6 hours; max 600 mg/day.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may cause neonatal withdrawal syndrome.
Key Drug Interactions
- Serotonergic drugs
- CNS depressants
- MAO inhibitors
Contraindications
- Hypersensitivity to tapentadol
- Respiratory depression
- Severe renal impairment
- Severe hepatic impairment
- Acute pancreatitis
Common side effects
- Nausea
- Dizziness
- Somnolence
- Headache
Counselling Points
- Take with sufficient liquid.
- Monitor for signs of abuse.
- Avoid driving or operating machinery.
Serious warnings
- Potential for abuse
- Respiratory depression
- Seizure risk
Important Disclaimer
The Palexia Range 50 mg. 75 mg. 100 mg Tablet. professional information leaflet below is the property of Janssen Pharmaceutica and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
